Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

PBS. 2015; 5(3): 120-5


Antipsychotic like effects of atorvastatin and melatonin in a psychosis model in rats

Volkan Solmaz, Dursun Delibas, Sema Inanir, Oytun Erbas.




Abstract

Objective: In recent years besides dopaminergic imbalance exhibition of other possible mechanisms like inflammation and serotonergic abnormalities have pointed out the need for new antipsychotic drugs. In this study our aim was investigating the effects of atorvastatin and melatonin in experimental psychosis model in rats.
Materyal and Methods: Apomorphine-induced stereotypy has been used as a convenient method for in vivo screening of dopamine agonists or antagonists, and assessment of dopaminergic activity. All rats were observed and assessed singly in the Plexiglas cage, 7 (n=6) groups of rat were administered atorvastatin (10, 20 mg/kg, i.p.), melatonin (10, 20 mg/kg, i.p.), 1% ethanol sham (1 ml/kg, i.p.) chlorpromazine (1 mg/kg; i.p.) or isotonic NaCl (1 ml/kg, i.p.). After apomorphine administration, the rats were immediately placed back into the metal cages and observed for stereotypic and rearing behaviors for 15 minutes.
Results: Whereas 20 mg/kg of atorvastatin and 20 mg/kg of melatonin decreased rearing behavior scores compared to saline group significantly (p

Key words: psychosis, statin, melatonin, stereotypy






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.